glp-1 therapy protein intake optimization research Application of nutrition interventions with based therapies: A narrative review of the challenges and solutions Protein Intake for GLP-1 Users

Description

Subgroup analyses indicated that this risk was particularly elevated in individuals receiving high-dose treatment, in studies of long-acting agents, and in overweight/obese populations

Accessed April 2019

Ozempic, Rybelsus, Saxenda, Victoza, Wegovy, Mounjaro, Trulicity and Zepbound remain approved by the U.S

Obesity, sleep apnea, and hypertension

FDA regulations for prescription drug advertisements apply to compounded drugs and only contain a limited exception for certain compounded drugs which is not applicable to the Advertisement.[11] The APC has asserted that because the Advertisement is a help-seeking advertisement that does not promote a specific drug or medication, it is not required to provide information about side effects or risks